Citigroup
DNA icon

Citigroup’s Ginkgo Bioworks DNA Stock Holding History

Citigroup’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.4K Buy
3,164
+1,993
+170% +$16.6K ﹤0.01% 4834
2025
Q4 		$9.73K Sell
1,171
-1,703
-59% -$18.3K ﹤0.01% 5065
2025
Q3 		$41.9K Sell
2,874
-16,216
-85% -$194K ﹤0.01% 4551
2025
Q2 		$215K Buy
19,090
+14,668
+332% +$114K ﹤0.01% 4032
2025
Q1 		$25.2K Sell
4,422
-75,038
-94% -$764K ﹤0.01% 5045
2024
Q4 		$780K Buy
79,460
+50,609
+175% +$434K ﹤0.01% 3540
2024
Q3 		$235K Buy
28,851
+9,581
+50% +$96K ﹤0.01% 4234
2024
Q2 		$258K Sell
19,270
-14,964
-44% -$446K ﹤0.01% 3760
2024
Q1 		$1.59M Buy
34,234
+20,756
+154% +$1.07M ﹤0.01% 2632
2023
Q4 		$911K Sell
13,478
-1,182
-8% -$72.4K ﹤0.01% 2904
2023
Q3 		$1.06M Sell
14,660
-4,432
-23% -$354K ﹤0.01% 2461
2023
Q2 		$1.42M Sell
19,092
-1,126
-6% -$66.7K ﹤0.01% 2535
2023
Q1 		$1.08M Sell
20,218
-830
-4% -$52.6K ﹤0.01% 2485
2022
Q4 		$1.42M Buy
21,048
+3,609
+21% +$332K ﹤0.01% 2299
2022
Q3 		$2.18M Sell
17,439
-583
-3% -$69.5K ﹤0.01% 2086
2022
Q2 		$1.72M Sell
18,022
-11,007
-38% -$1.34M ﹤0.01% 2216
2022
Q1 		$4.68M Buy
29,029
+28,291
+3,833% +$5.51M ﹤0.01% 1712
2021
Q4 		$245K Buy
+738
New +$351K ﹤0.01% 4236

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's DNA Position: Q1 2026 in Review

Citigroup increased its Ginkgo Bioworks (DNA) stake by 170% in Q1 2026, buying an estimated $16.6K and bringing the position to 3,164 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4834.

Citigroup first reported a position in DNA in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.68M in Q1 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Citigroup held 3,164 shares of Ginkgo Bioworks worth $19.4K as of Q1 2026.
  • Citigroup bought 1,993 Ginkgo Bioworks shares in Q1 2026, an estimated $16.6K.
  • Ginkgo Bioworks made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4834 holding.
  • Citigroup first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 18 quarters since.
  • Citigroup's Ginkgo Bioworks position peaked at $4.68M in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.